Genenta Science (GNTA) Short Interest Ratio & Short Volume → Who are Nvidia’s Silent Partners? (From Weiss Ratings) (Ad) Free GNTA Stock Alerts $3.30 +0.27 (+8.91%) (As of 05/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Genenta Science Short Interest DataCurrent Short Interest4,800 sharesPrevious Short Interest3,900 sharesChange Vs. Previous Month+23.08%Dollar Volume Sold Short$14,784.00Short Interest Ratio0.8 Days to CoverLast Record DateApril 30, 2024Outstanding Shares18,220,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume3,131 sharesAverage Trading Volume5,269 sharesToday's Volume Vs. Average59% Short Selling Genenta Science ? Sign up to receive the latest short interest report for Genenta Science and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNTA Short Interest Over TimeGNTA Days to Cover Over TimeGNTA Percentage of Float Shorted Over Time Ad Weiss RatingsWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” Genenta Science Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,800 shares $14,784.00 +23.1%N/A0.8 $3.08 4/15/20243,900 shares $13,123.50 +30.0%N/A0.7 $3.37 3/31/20243,000 shares $10,500.30 -9.1%N/A0.7 $3.50 3/15/20243,300 shares $12,870.00 -5.7%N/A0.8 $3.90 2/29/20243,500 shares $15,399.65 -5.4%N/A1.2 $4.40 2/15/20243,700 shares $14,800.00 +5.7%N/A1.3 $4.00 Get the Latest News and Ratings for GNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,500 shares $14,105.00 -5.4%N/A1.3 $4.03 1/15/20243,700 shares $16,465.00 No ChangeN/A1.8 $4.45 12/31/20233,700 shares $18,315.00 -32.7%N/A1.7 $4.95 12/15/20235,500 shares $27,610.00 +14.6%N/A2.5 $5.02 11/30/20234,800 shares $23,760.00 -35.1%N/A2.4 $4.95 11/15/20237,400 shares $38,480.00 +37.0%N/A3.9 $5.20 10/31/20235,400 shares $28,836.00 -25.0%N/A3.2 $5.34 10/15/20237,200 shares $40,248.00 +1.4%N/A3.8 $5.59 9/30/20237,100 shares $36,565.00 +10.9%N/A4.4 $5.15 9/15/20236,400 shares $36,032.00 -1.5%N/A3.6 $5.63 8/31/20236,500 shares $37,700.00 -17.7%N/A3.2 $5.80 8/15/20237,900 shares $43,687.00 +9.7%N/A3.4 $5.53 7/31/20237,200 shares $39,168.00 +50.0%N/A3 $5.44 7/15/20234,800 shares $28,560.00 -14.3%N/A2.2 $5.95 6/30/20235,600 shares $32,984.00 +7.7%N/A2.7 $5.89 6/15/20235,200 shares $29,848.00 +300.0%N/A2.4 $5.74 5/31/20231,300 shares $7,932.73 -23.5%N/A0.5 $6.10 5/15/20231,700 shares $9,537.00 +54.6%N/A0.7 $5.61 4/30/20231,100 shares $6,600.00 +266.7%N/A0.4 $6.00 4/15/2023300 shares $1,890.00 No ChangeN/A0.1 $6.30 3/31/2023300 shares $1,725.00 -40.0%N/A0.1 $5.75 3/15/2023500 shares $3,350.00 -66.7%N/A0.1 $6.70 2/28/20231,500 shares $9,750.00 +114.3%N/A0.3 $6.50 2/15/2023700 shares $4,585.00 -22.2%N/A0.2 $6.55 1/31/2023900 shares $5,526.00 -50.0%N/A0.2 $6.14 1/15/20231,800 shares $11,610.00 -30.8%N/A0.4 $6.45 12/30/20222,600 shares $14,300.00 +116.7%N/A0.6 $5.50 12/15/20221,200 shares $6,780.00 +140.0%N/A0.4 $5.65 11/30/2022500 shares $2,605.00 -80.8%N/A0.2 $5.21 11/15/20222,600 shares $10,816.00 +225.0%N/A1.2 $4.16 10/31/2022800 shares $3,520.00 +33.3%N/A0.4 $4.40 10/15/2022600 shares $2,742.00 -25.0%N/A0.3 $4.57 9/30/2022800 shares $3,983.92 -11.1%N/A0.3 $4.98 9/15/2022900 shares $4,719.33 +125.0%N/A0.3 $5.24Who are Nvidia’s Silent Partners? (Ad)Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” 8/31/2022400 shares $2,368.00 -71.4%N/A0.1 $5.92 8/15/20221,400 shares $8,876.00 -12.5%N/A0.4 $6.34 7/31/20221,600 shares $10,512.00 -46.7%N/A0.3 $6.57 7/15/20223,000 shares $20,220.00 No ChangeN/A0.6 $6.74 GNTA Short Interest - Frequently Asked Questions What is Genenta Science's current short interest? Short interest is the volume of Genenta Science shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 4,800 shares of GNTA short. Learn More on Genenta Science's current short interest. What is a good short interest ratio for Genenta Science? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNTA shares currently have a short interest ratio of 1.0. Learn More on Genenta Science's short interest ratio. Is Genenta Science's short interest increasing or decreasing? Genenta Science saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 4,800 shares, an increase of 23.1% from the previous total of 3,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Genenta Science's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Genenta Science: Protara Therapeutics, Inc. (5.00%), Aligos Therapeutics, Inc. (1.07%), Dyadic International, Inc. (0.96%), Cidara Therapeutics, Inc. (2.04%), Curis, Inc. (1.14%), Turnstone Biologics Corp. (5.22%), IN8bio, Inc. (0.60%), Ikena Oncology, Inc. (5.99%), OKYO Pharma Limited (0.43%), Cyclo Therapeutics, Inc. (0.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Genenta Science stock? Short selling GNTA is an investing strategy that aims to generate trading profit from Genenta Science as its price is falling. GNTA shares are trading up $0.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genenta Science? A short squeeze for Genenta Science occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNTA, which in turn drives the price of the stock up even further. How often is Genenta Science's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNTA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Protara Therapeutics Short Squeeze Aligos Therapeutics Short Squeeze Dyadic International Short Squeeze Cidara Therapeutics Short Squeeze Curis Short Squeeze Turnstone Biologics Short Squeeze IN8bio Short Squeeze Ikena Oncology Short Squeeze OKYO Pharma Short Squeeze Entera Bio Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNTA) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis could mean the end of the U.S dollar…Colonial MetalsThis military-backed stock “owns” AI marketPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin Analytics